Skip to main content
. 2024 Dec 4;11:1489671. doi: 10.3389/fmed.2024.1489671

Figure 2.

Figure 2

Evolution of therapeutic response to pegylated interferon-α-2b over 48 weeks in all enrolled patients with hepatitis B virus-related compensated liver cirrhosis. (A) Changes of serum HBsAg level at different observational time points. The points indicate median, while the bars indicate interquartile range. Statistical analyses were performed using Kriskal-Wallis H test followed by Dunn’s multiple comparison test. (B) Change of liver stiffness measurement (LSM) at 48 weeks compared with baseline. (C) Change of thickness of spleen at 48 weeks compared with baseline. (D) Change of length of spleen at 48 weeks compared with baseline. (E) Change of diameter of portal vein at 48 weeks compared with baseline. The central lines indicate median or mean, the boxes indicate standard deviation or interquartile range, and the bars indicate the minimum to maximum range. Statistical analyses were performed using Mann–Whitney U test or Student’s t-test.